Cannabis Law Report

JANUARY 27, 2020

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59

Safety CBD Food Seed-To-Sale 59

NORML

AUGUST 29, 2019

” Specifically, federal and state data finds that teen cannabis use has declined in past years – during the same time that many states have legalized and regulated the use of cannabis by adults. According to an August 2019 federal report , past-year marijuana use by those ages 12 to 17 has fallen consistently since 2002, from 15.8

Education 227

Education Data Retail Environment 227

Cannabis Law Report

JULY 13, 2021

As the psychedelic renaissance contributes to a swelling pool of safety and efficacy data pertaining to the potential therapeutic benefits of psychedelic medicine, many localities—particularly in North America—are revising their legal frameworks. This is what they are saying. Mapping Psychedelic Drug Policy Reform. A number of U.S.

Decriminalization 105

Decriminalization Legalization Data Safety 105

Cannabis Law Report

JANUARY 31, 2019

January 31, 2019. Portland, OR — Today the Oregon Liquor Control Commission provided the Oregon Legislative Assembly with the 2019 Recreational Marijuana Supply and Demand Legislative Report required by ORS 475B.548. 2019 Recreational Marijuana Supply and Demand Legislative Report. Here’s the statement in full.

Legislation 61

Legislation Recreational Marijuana Policy 61

NORML

NOVEMBER 4, 2019

Use of the term ‘cannabis’ instead of ‘marijuana’ does not influence the public’s perception of the plant or their attitudes, according to data published in the journal PLOS One. ” Full text of the study, “Has the ‘M’ word been framed?

Policy 150

Policy Topical Data Safety 150

Cannabis Law Report

OCTOBER 9, 2021

Data from the Denver District Attorney’s office shows only 47 cases related to psychedelic mushrooms since May 2019 decriminalization. The panel that includes District Attorney Beth McCann, law enforcement officers and psilocybin advocate Kevin Matthews was formed after 2019, when Denver voters were the first in the U.S.

Decriminalization 52

Decriminalization Law Data Safety 52

Cannabis Law Report

AUGUST 22, 2021

But for now, the developers are focused on creating a training that emphasizes compassionate response, de-escalation, and the safety and well-being of individuals having a challenging time with a psychedelic experience. First responders in Denver, Colorado, will soon have another tool to support their community: psychedelic harm reduction.

Research and Development 105

Research and Development Decriminalization Education Safety 105

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

JUNE 10, 2021

The Traffic Safety Culture Index is an annual survey with national scope and multiple measures relevant to driving after marijuana use. Because THC presence is an imperfect proxy for impairment [ 10 ], driving data may be limited in clarifying what traffic safety risks, if any, are associated with permissive marijuana policies.

Policy 59

Policy Safety Marijuana Data 59

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

NOVEMBER 11, 2021

In May 2019, Denver became the first city in the United States to decriminalize personal possession, cultivation and storage of psilocybin mushrooms. The initiative also created the Denver Psilocybin Policy Review Panel (“Panel”), which was required to report back to the City on the public safety and other impacts of decriminalization.

Policy 52

Policy Decriminalization Safety Therapy 52

Cannabis Law Report

AUGUST 11, 2021

“FDA continually asked the companies for meetings and safety data about their products containing full-spectrum hemp extract. After complying with FDA’s requests, these companies saw FDA reject their NDI notifications—disregarding published peer-reviewed toxicology studies and years’ worth of real-world safety evidence.

Extraction 98

Extraction Hemp CBD Safety 98

Dykema (Cannabis Law Blog)

MARCH 9, 2020

The FDA is reopening the public docket established in May 2019 for the submission of data related to the efficacy and safety of Cannabidiol. The docket includes a mechanism for stakeholders to submit data and information that is confidential. Read More › Tags:

Data 40

Data Safety 40

Cannabis Law Report

MAY 30, 2019

Friday, May 31st, 2019. . at the Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing on Friday, May 31, 2019. If you are interested in submitting comments after the hearing, comments must be posted to the public docket before July 2, 2019.

Law 69

Law Data Safety Food 69

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. 2019 Mar; 4(1): 73–84. Tuberous Sclerosis Association website.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

The Blunt Truth

AUGUST 13, 2019

In March of 2019, the FDA established a Working Group to determine the possible legislative pathways to regulate CBD. On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 105

Clinical Trials Patients THC Safety 105

Canna Law Blog

OCTOBER 25, 2022

In January 2019, the catalog was amended to classify extracts from industrial hemp containing cannabinoids as a novel food. The purpose of the Novel Food Regulation is to ensure a high level of protection in food safety. What are the main challenges for a hemp/cannabis/CBD businesses seeking a Novel Food authorization?

Food 86

Food Hemp Safety Cannabinoids 86

Cannabis Law Report

JUNE 17, 2022

The bill’s protections do not extend to employees whose “position is designated as safety sensitive.” In 2019, Mayor Bowser signed an order into law eliminating random drug testing for District employees in non-safety sensitive positions.

Safety 52

Safety Legislation Policy Cannabis 52

Veriheal

NOVEMBER 18, 2022

According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. Back in 2019 , the program was expanded to include ALL individuals with epilepsy—not just those with intractable epilepsy as the program had originally outlined.

Edibles 98

Edibles Hemp Epilepsy Programs 98

Cannabis Law Report

MARCH 19, 2020

FDA’s announcement comes on the heels of an active 2019, during which both FDA and the FTC issued warning letters to marketers of CBD products 1 and the plaintiffs’ bar began to actively file class-action lawsuits against marketers of CBD products under state law. FDA submitted this report last week, as is discussed below.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

Veriheal

AUGUST 28, 2020

The survey found that from 2009-2019 there were “no change” in the rate of cannabis consumption among high school students. Using the same data analyzed under a quadratic change model, lifetime cannabis consumption showed a clear decrease during that same time period. According to the recent CDC report, 21.7%

Consumption 52

Consumption Legalization Data Policy 52

Marijuana Lawyer Blog

FEBRUARY 9, 2020

Since its passing in 2016, Prop 64 has earmarked its entire cannabis industry tax revenue, minus regulatory costs, to supporting public health, repairing the environment, and bettering public safety. Marijuana Tax Revenue Expenditures in California (Fiscal Year 2019-2020). 20 percent to public safety initiatives.

Marijuana 64

Marijuana Safety Programs Dispensary 64

The Cannigma

FEBRUARY 2, 2021

“Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

MARCH 11, 2022

Colorado marijuana dispensaries passed underage sales checks at a 95 percent rate in 2021, according to the MED, slightly down from 97 percent in 2020 and 2019. ” The MED conducted 604 underage compliance checks at dispensaries in 2019, according to department data, but that number dropped to 118 in 2020 and 80 in 2021.

Legislation 105

Legislation Seed-To-Sale Compliance Compliance 105

Cannabis Law Report

OCTOBER 13, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. Read the full article at [link].

Research and Development 52

Research and Development Therapy Access Data 52

SpeedWeed

JULY 29, 2021

According to most recent sales data on Colorado’s cannabis industry, the state has sold $962,071,139 between January and May of this year. A recent July report by the Colorado Division of Criminal Justice also found that cannabis-related arrests have decreased significantly, by 68 percent, between 2012 and 2019 (or from 13,225 to only 4,290).

Data 52

Data Collective Business Cannabis 52

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans.

Safety 52

Safety Research and Development Compliance Compliance 52

Cannabis Law Report

JUNE 19, 2022

Beckley Psytech will use Ksana Health’s Effortless Assessment Research System (EARS), an end-to-end solution for mobile sensing, to collect passive mobile device meta data from clinical trial participant’s smartphones, in order to identify individual signals of potential response and relapse. Ksana Health – www.ksanahealth.com.

Clinical Trials 52

Clinical Trials Patients Research and Development Treatment 52

Cannabis Law Report

DECEMBER 2, 2021

Generally, medicinal cannabis products are only available, on prescription, if they have: been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or. Sativex data sheet. Any doctor can prescribe a product listed here. Sativex Oral spray.

Medicine 52

Medicine Pharmaceutical Sativa THC 52

Cannabis Law Report

AUGUST 16, 2021

It is also a tool used to “determine the nature and scope of child abuse and neglect” and compare Arizona data to national trends, regardless of whether that neglect or abuse arose from the lawful or unlawful use of substances, a mental illness or incapacity, or simply an inability to properly care for a child. 600 USD raised of $400 goal.

Safety 116

Safety Patients Cannabis Law 116

WeedAdvisor

OCTOBER 11, 2019

Although things like quality, consistency and safety are all benefits of buying from the open market, some products are almost prohibitively expensive. Minister of Public Safety Mark Farnworth, who is confident that further price drops are on the horizon. The price of legal cannabis is a huge turn-off for consumers.

Legalization 66

Legalization Marijuana Safety Data 66

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

DECEMBER 19, 2021

Generally, medicinal cannabis products are only available, on prescription, if they have: been assessed by the Medicinal Cannabis Agency as meeting the minimum quality standard under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, or. Sativex data sheet. Any doctor can prescribe a product listed here. Sativex Oral spray.

Medicine 52

Medicine Pharmaceutical THC Sativa 52

Cannabis Law Report

NOVEMBER 6, 2019

5, 2019) — ValidCare, the hemp industry’s leading market intelligence and consumer research platform, and the University of Kentucky Research Foundation (UKRF) have announced they have entered into a services agreement to advance the research of hemp-derived products. LEXINGTON, Ky. About ValidCare.

Hemp 45

Hemp Data Access Education 45

Cannabis Law Report

AUGUST 23, 2021

In testimony before the US Senate in July 2019, Dr. Amy Abernethy, Principal Deputy Commissioner at FDA, stated that the Agency recognizes the need for “regulatory clarity, particularly given the significant public interest in hemp products, and CBD in particular.” Who’s responsible for regulating CBD in pet products?

Pets 105

Pets Hemp CBD Food 105